This study reveals that kaempferol suppresses colorectal cancer progression by dual targeting of glucose metabolism (reducing UDP-GlcNAc flux) and OGT activity, thereby diminishing O-GlcNAcylation of Hsp47. Here, OGT is linked to colorectal cancer.